Inactive

Page 3 of 3 Subject: Sources Sought, Reverse Distribution Narcotic Destruction for VA Northern California Health Care System (VANCHCS), Department of Veterans Affairs, Veterans Health Administration (... Page 3 of 3 Subject: Sources Sought, Reverse Distribution Narcotic Destruction for VA Northern California Health Care System (VANCHCS), Department of Veterans Affairs, Veterans Health Administration (VHA). The purpose of this sources sought is to conduct market research to support the procurement of Reverse Distribution Narcotic Destruction for VA Northern California. This notice serves to survey the market in an attempt to ascertain whether or not, sources can provide the requested services. This notice allows potential contractors/vendors to submit a non-binding statement of interest and documentation demonstrating their capability. The sources sought effort is intended to assess industry capabilities and develop/support the intended direction of acquisition planning. This source sought is to gain knowledge of potential qualified sources and their size classifications. Responses to this notice, will be used by the Government to make appropriate acquisition decisions. After review of the responses to this notice, a solicitation announcement may be published. Responses to this notice are not considered adequate responses to any corresponding solicitation announcement. All interested offerors will have to respond to the solicitation announcement in addition to responding to this notice. MINIMUM TECHNICAL REQUIREMENTS: On-Site Process: Controlled substance items held for destruction are placed in an evident tamper bag. All bags shall be opened at the time of the transfer to a DEA-licensed destruction company and must be verified in the presence of the representative of the reverse distributor, pharmacy staff and an Accountable Officer (AO). The AO, pharmacist and representative from destruction company must sign the document listing of the controlled substances transferred from VA to the destruction company. The reverse distributor must provide a signed receipt for all CIII-V and DEA Form 222 for all CII products taken at the time of transfer. The CIII-V receipt and DEA Form 222 must include drug name, dosage form, strength, exact quantity, and date of transfer. The pharmacy must maintain these records for three years in a readily retrievable manner. Once the on-site representative of the contractor verifies counts with the pharmacy staff and accountable officer and completes the paperwork of the transfer, and preparation for shipping the reverse distributor shall assume the title and responsibility to the products. Prior to boxing items, a pharmacy employee shall review with contractor during on-site service a list of items to ensure it matches that of what is actually acquired by reverse distributor and ensure there are no discrepancies between the pharmacy s list of items and contractors list of items. Contractor shall be responsible for boxing up items acquired by the pharmacy and arranging for pick-up by carrier. On-site representative shall arrange for immediate pick up by trusted carrier or shall have a DEA compliant transport process. The DEA registered reverse distributor who destroys the controlled substance must submit a DEA Form 41 to the DEA when the controlled substances have been destroyed. The DEA Form 41 should not be used to document the transfer of controlled substances from the pharmacy to the reverse distributor. A copy of the DEA Form 41 should be sent to pharmacy point of contact. A reverse distributor shall acquire controlled substances from a registrant at the registrant s registered location or receive controlled substances delivered by common or contract carrier. Controlled substances for destruction shall occur no later than 30 calendar days after receipt. A method of destruction shall render controlled substances for destruction non-retrievable in compliance with federal regulations. Description of Items Eligible for Transfer: Vendor shall accept any Scheduled CII-V medications being held for destruction obtained through return mail or otherwise deemed unusable or expired. All forms of medication shall be accepted such as tablets, capsules, suppositories, liquids, refrigerated items, patches, films, topicals, unused syringes containing medication but may not be limited to this list. Scheduled CII-V medications not contained in original manufacturer bottle packaging shall also be accepted for return. All controlled medications shall be counted and verified by vendor in presence of pharmacy staff member and VA accountable officer. Supplies and Services: The vendor shall be fully licensed to perform the work and shall take responsibility to complete details of the contract from start to finish. The responsibilities of the contractor shall include the ability to provide on-site and off-site services and provide all equipment, materials, and labor needed to process and arrange for proper disposal of Schedule II-V controlled substances. The vendor shall bring all necessary supplies including equipment or software for their own use to perform their work as reverse distributor to each on-site pick-up. Vendor shall be responsible for their supplies and equipment including any loss or damage. Reverse distributor shall be responsible for packaging products transferred to them if shipping through carrier, including but not limited to generating shipping labels and providing compliant packaging. Software or Web-based System: Vendor shall provide the COR and designated pharmacy staff access to software programs or web-based programs to identify which products have been sent for destruction. The Contractor shall list all controlled substance medications designated for disposal on a disposal manifest. This list will include at a minimum product name, National Drug Code (NDC) or catalog number, quantity, total estimated value. Separate manifests shall be provided for the disposal of Schedule II V controlled substances and when disposing of hazardous waste products as defined by the EPA Resource Conservation and Recovery Act (RCRA) regulations. A Certificate of Destruction including the disposal date, destruction method, destruction location, weight, disposal company name and proof of destruction affidavit shall be provided to the returning facility and maintained on the reporting website upon completion of destruction. All Manifests shall be provided to the returning facility within 30 calendar days of Contractor's item receipt, with the exception of the Certificate of Destruction/Affidavit which shall be provided within 30 days of the completion of destruction. Shipments to the Contractor that require transport to the disposal location shall be done via approved and licensed vehicles in accordance with federal, state, and local laws and regulations where the processing will be completed. Contractor spills or releases of toxic/hazardous substances into the environment shall be reported to the returning facility immediately. Training shall be provided to COR and designated staff on utilization of this software. Representative or customer service should be available and able to provide efficient service support for staff for as needed assistance or questions at no additional charge for the entire duration of the resulting contract. Web Based platforms must conform to VA rules, regulation and policy and must be reviewed by the ISSO before any agreement can be made. In addition to ISSO review, cloud-based platforms must be Fed Ramp compliant or have solidified plans to be compliant within a time frame necessary to carry out the duties of the contract. Disposal and Destruction: A complete list of medications processed for destruction shall be provided by on-site representative. Access to software shall be provided to designated individuals to track the destruction of such medications. CII-V medications and CII medications should be listed separately so VA designated staff will have access to view the disposal manifest and DEA Form 41 for CII destruction. INSTRUCTIONS: Submit a brief description, two-three (2-3) pages (including cover letter) that demonstrates how your company can provide the requested services. Include past-experience, with providing these services to the VA, other Government (Federal or State) agency, or for a private facility. Please specify your availability and your address. If any portions seem unclear, prohibited, and/or you are unsure about the draft description of the requirement please list your comments and/or concerns in your response, so they can be addressed. PLEASE INDICATE WHETHER YOU HOLD A GSA FEDERAL-SUPPLY SCHEDULE CONTRACT THAT COVERS THIS EQUIPMENT AND/OR SERVICES AND, IF SO, THE CONTRACT NUMBER. Provide BUSINESS SIZE AND SOCIO-ECONOMIC STATUS; Your response should include a STATEMENT OF CAPABLILITY, GSA SCHEDULE INFORMATION, DUNS#, BUSINESS SIZE, AND SOCIO-ECONOMIC STATUS information as explained above. Response is due by 12pm EST on September 19, 2022. Please submit e-mail responses to Rachael Becker, Contract Contracting Officer, at email address: Rachael.Becker@va.gov NOTE: Issuance of this notice does not constitute any obligation whatsoever on the part of the Government to procure this equipment and/or services, or to issue a solicitation, nor to notify respondents of the results of this notice. No solicitation documents exist at this time; however, in the event the acquisition strategy demonstrates that GSA is a viable option for procuring a solution, the RFQ shall be posted to GSA eBuy where only those firms who currently hold a GSA Schedule with the applicable SIN will be able to respond. The Department of Veterans Affairs is neither seeking quotes nor accepting unsolicited quotes, and responses to this notice cannot be accepted as offers. Any information the vendor considers proprietary should be clearly marked as such. The U.S. Government will not pay for any information or administrative costs incurred in response to this RFI.